Come up with a name for your new list and we'll add to it:
Cognition Therapeutics raised a round of funding on May 23, 2018. Investors include
National Institute on Aging.
Cognition Therapeutics is focused on the discovery and development of small molecule therapeutics targeting toxic proteins that cause the cognitive decline associated with Alzheimer's disease and othe…